Clinical Trial Update: A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm

View source ↗

Summary

A retrospective chart review evaluating the use of Botox (onabotulinumtoxinA) and Xeomin (incobotulinumtoxinA) for managing cervical dystonia and blepharospasm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm
• Cervical Dystonia

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Allergan | Conditions: Cervical Dystonia, Blepharospasm | Status: COMPLETED